Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder
ALISO VIEJO, Calif., Oct. 7, 2026 /PRNewswire/ -- Okami Medical, a medical technology company developing novel vascular embolization solutions, announced today that the U.S. FDA has granted an expanded indication for its LOBO® Vascular Occlusion System. The expanded indication extends the...
Short extract only — this publisher licenses its text. Read the full release at the source.
Cancel anytime · CA$99/month


